Sveriges mest populära poddar

Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)

8 min•24 augusti 2016

Om avsnittet

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Michael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny.

See omnystudio.com/listener for privacy information.

Fler avsnitt

What The Bond Selloff Means For Your Wallet & Simplifying Finance For Your Family

26 sep.48 min

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013

25 sep.18 min

Meta Introduces Palm-Sized Device to Use Muse AI

24 sep.19 min

Disney+ Price to Jump 13% to $21.49 Per Month

23 sep.22 min

Meta’s New Muse AI App Makes Shopping Easier

22 sep.17 min

Paramount to Settle Lawsuits Against WBD Deal

21 sep.19 min

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.

Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)

Om avsnittet

Fler avsnitt

Micron Gives Bullish Forecast, Even as Pay Raises Crimp Margins

Apple Is Ready to Make Long-Awaited Push Into Smart-Home Market

Smart Ring Maker Oura Delays IPO

Nvidia Boosts Share Buyback Program by $150 Billion